Terms: = Breast cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Treatment
106 results:
1. Impact of Short-Term Creatine Supplementation on Muscular Performance among breast cancer Survivors.
Parsowith EJ; Stock MS; Kocuba O; Schumpp A; Jackson K; Brooks AM; Larson A; Dixon M; Fairman CM
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613014
[TBL] [Abstract] [Full Text] [Related]
2. Comparing the use of aggressive end-of life care among frail and non-frail patients with cancer using a claims-based frailty index.
Sachdev R; Shearn-Nance G; Vu L; Bensken WP; Douglas SL; Koroukian SM; Rose J
J Geriatr Oncol; 2024 Mar; 15(2):101706. PubMed ID: 38320468
[TBL] [Abstract] [Full Text] [Related]
3. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
4. Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage breast cancer.
Roy AM; Patel A; Catalfamo K; Attwood K; Khoury T; Yao S; Gandhi S
JAMA Netw Open; 2023 Nov; 6(11):e2344517. PubMed ID: 37991763
[TBL] [Abstract] [Full Text] [Related]
5. [High expression of secretogranin II increases oxaliplatin resistance of colorectal cancer cells].
Deng J; Pan T; Zhou G; Gao Y; Peng W; Wei W; Lü C
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1657-1664. PubMed ID: 37933640
[TBL] [Abstract] [Full Text] [Related]
6. The direct medical cost of breast cancer management in a provincial hospital of Papua New Guinea: A cost of illness study of consecutive patients from 2017 to 2022.
Umo I; Kulai M; Umo P; James K; Ikasa R
J Cancer Policy; 2023 Dec; 38():100447. PubMed ID: 37813161
[TBL] [Abstract] [Full Text] [Related]
7. breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy.
Šušak Sporiš I; Božina N; Klarica Domjanović I; Sporiš D; Bašić S; Bašić I; Lovrić M; Ganoci L; Trkulja V
Fundam Clin Pharmacol; 2024 Apr; 38(2):351-368. PubMed ID: 37793994
[TBL] [Abstract] [Full Text] [Related]
8. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
[TBL] [Abstract] [Full Text] [Related]
9. Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic breast cancer.
Rugo HS; Liu X; Li B; McRoy L; Chen C; Layman RM; Brufsky A
Oncologist; 2023 Oct; 28(10):866-874. PubMed ID: 37487056
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of different cyclin-dependent kinase inhibitors and KI-67 levels on survival and toxicity in breast cancer treatment.
Bayram E; Selvi O; Köşeci T; Mete B; Yaslıkaya Ş; Paydaş S
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5230-5239. PubMed ID: 37318497
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of initial and sequential salvage brain-directed treatment in patients with 1-4 vs. 5-10 brain metastases from breast cancer (KROG 16-12).
Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
Breast Cancer Res Treat; 2023 Jul; 200(1):37-45. PubMed ID: 37138198
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies.
Shimizu R; Matsuzaki T; Oka R; Sonoyama T; Fukuhara T; Kuwata A; Matsuo Y; Kubota R
J Clin Pharmacol; 2023 Aug; 63(8):918-927. PubMed ID: 37043676
[TBL] [Abstract] [Full Text] [Related]
13. Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With breast cancer.
Mo H; Yan X; Zhao F; Teng Y; Sun X; Lv Z; Cao M; Zhao J; Song G; Pan B; Li H; Zhai J; Xu B; Ma F
JAMA Netw Open; 2022 Nov; 5(11):e2239788. PubMed ID: 36322088
[TBL] [Abstract] [Full Text] [Related]
14. Follow-up strategy and survival for five common cancers: A meta-analysis.
Galjart B; Höppener DJ; Aerts JGJV; Bangma CH; Verhoef C; Grünhagen DJ
Eur J Cancer; 2022 Oct; 174():185-199. PubMed ID: 36037595
[TBL] [Abstract] [Full Text] [Related]
15. Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With cancer.
Taparra K; Qu V; Pollom E
JAMA Netw Open; 2022 Aug; 5(8):e2226327. PubMed ID: 35960520
[TBL] [Abstract] [Full Text] [Related]
16. Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive breast cancer.
Gao C; Li H; Zhou C; Liu C; Zhuang J; Liu L; Sun C
Front Endocrinol (Lausanne); 2022; 13():813306. PubMed ID: 35663326
[TBL] [Abstract] [Full Text] [Related]
17. Clinical evaluation of two AI models for automated breast cancer plan generation.
Kneepkens E; Bakx N; van der Sangen M; Theuws J; van der Toorn PP; Rijkaart D; van der Leer J; van Nunen T; Hagelaar E; Bluemink H; Hurkmans C
Radiat Oncol; 2022 Feb; 17(1):25. PubMed ID: 35123517
[TBL] [Abstract] [Full Text] [Related]
18. Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced breast cancer after Progression on Aromatase Inhibitor.
García-Sáenz JÁ; Martínez-Jáñez N; Cubedo R; Jerez Y; Lahuerta A; González-Santiago S; Ferrer N; Ramos M; Alonso-Romero JL; Antón A; Carrasco E; Chen J; Neuwirth R; Galinsky K; Vincent S; Leonard EJ; Slamon D
Clin Cancer Res; 2022 Mar; 28(6):1107-1116. PubMed ID: 34980598
[TBL] [Abstract] [Full Text] [Related]
19. Overview of PROTACs Targeting the Estrogen Receptor: Achievements for Biological and Drug Discovery.
Qin H; Zhang Y; Lou Y; Pan Z; Song F; Liu Y; Xu T; Zheng X; Hu X; Huang P
Curr Med Chem; 2022; 29(22):3922-3944. PubMed ID: 34758713
[TBL] [Abstract] [Full Text] [Related]
20. Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations.
Mili N; Paschou SA; Goulis DG; Dimopoulos MA; Lambrinoudaki I; Psaltopoulou T
Endocrine; 2021 Dec; 74(3):478-497. PubMed ID: 34625915
[TBL] [Abstract] [Full Text] [Related]
[Next]
